Next-Generation Approaches in Clinical Antiviral Therapy: From Bench to Bedside

Dear Colleagues,

The rapid emergence and re-emergence of viral pathogens—including SARS-CoV-2, dengue virus, influenza, and viral hepatitis—continue to challenge global public health and highlight the urgent need for advanced antiviral therapies. This Special Issue, “Next-Generation Approaches in Clinical Antiviral Therapy: From Bench to Bedside,” aims to present cutting-edge research and clinical insights into the development, evaluation, and optimization of antiviral agents. Topics of interest include novel drug discovery platforms, host-targeted antivirals, drug repurposing, combination therapies, resistance mechanisms, and clinical trial updates. In addition, we welcome contributions exploring immunomodulatory and phytochemical compounds with antiviral potential, as well as translational studies bridging laboratory findings with clinical outcomes.

By gathering high-impact original research articles, reviews, and short communications, this Special Issue seeks to advance our understanding of antiviral therapeutics across a wide range of viral infections. The collection will serve as a valuable resource for clinicians, researchers, and pharmaceutical scientists striving to enhance treatment efficacy, reduce drug resistance, and develop safe, broad-spectrum antiviral interventions for emerging and established viral diseases.

Dr. Pouya Hassandarvish
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.